Year: 2016

UPCI Study Underlines the Importance of Routine Skin Cancer Screening

Skin cancer is the most common type of cancer worldwide. The most deadly form of skin cancer, melanoma, kills about 10,000 Americans per year. Routine screening enables earlier detection of skin lesions, when they are thinner and localized and can

Key Mechanisms of Cancer, Aging and Inflammation Uncovered

A team of researchers led by Patricia Opresko, PhD, Associate Professor of Environmental and Occupational Health at Pitt, and member of the UPCI Molecular and Cellular Cancer Biology Program and Carnegie Mellon University Center for Nucleic Acids Science and Technology,

Dr. Stanley Marks Honored with Endowed Chair in His Name to Recruit Cancer Leaders

Stanley Marks, MD, a leading UPMC oncologist and advocate for cancer patients throughout the western Pennsylvania region, was honored this month by UPMC and his medical partners at Oncology Hematology Association (OHA) through the establishment of the Stanley M. Marks

UPCI-led Studies Presented at ASTRO 2016 Annual Meeting

The annual meeting of the American Society for Radiation Oncology (ASTRO) was held in Boston this week, and several UPCI investigators presented their novel research findings related to improving treatment for cancer patients. Watch Dwight Heron, MD, FACRO, FACR discuss

‘Starving’ Immune Cell Discovery Points to Cancer Immunotherapy-Boosting Strategies

The microenvironment that supports a cancerous tumor also starves the immune cells that the body sends in to destroy the cancer, UPCI scientists revealed in a discovery that holds the potential to significantly boost the performance of breakthrough immunotherapy drugs.

Pennsylvania Cancer Consortium Established to Conduct Phase 2 Clinical Trials under New Award from the National Cancer Institute

UPCI’s Phase 1 clinical trials team, under the leadership of Edward Chu, MD and Jan Beumer, PharmD, PhD was recently awarded a three-year supplement to their UM1 Phase 1 grant from the National Cancer Institute (NCI) to support the conduct

New NCI Grant Funds Collaborative Effort to Improve Early Detection of Pancreatic Cancer

A majority of pancreatic cancer patients (>80%) present with a surgically unresectable primary tumor with distant metastasis at the time of diagnosis due to the lack of associated symptoms and lack of methods for early detection. While the overall 5-year

Big Data Researchers Aim to Build Better Models to Predict Cancer Outcomes

A team of “big data” researchers at the University of Pittsburgh and Carnegie Mellon University, in collaboration with UPMC and the Pittsburgh Supercomputing Center, are working to develop better methods for integrating, analyzing and modeling large volumes of diverse data

E-Cigarettes: Helpful or Harmful?

Brian Primack, MD, PhD, Professor of Medicine, Pediatrics, and Clinical and Translational Science; Assistant Vice Chancellor for Research on Health and Society; and Director of the Center for Research on Media, Technology, and Health, is a top tobacco-use expert whose

Depressed Patients at Higher Risk for Complications and Hospital Readmission after Complex Cancer Surgery

Cancer patients who report significant symptoms of depression before undergoing a complex abdominal surgery are at increased risk of postoperative complications and unplanned hospital readmissions, according to a UPCI study published recently in the Journal of Clinical Oncology. The study

Top